Amy Conrad | Investor Relations, Juniper Point |
Erik Holmlin | President and Chief Executive Officer |
Alka Chaubey | Chief Medical Officer |
Christopher Stewart | Chief Financial Officer |
Kevin DeGeeter | Oppenheimer & Co. |
Destiny Hance | Ladenburg Thalmann |
Michael Okunewitch | Maxim Group |
Good day and welcome to the Bionano Genomics First Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead.
Thank you, Latif.